Pages that link to "Q34991017"

The following pages link to Two classes of broadly neutralizing antibodies within a single lineage directed to the high-mannose patch of HIV envelope (Q34991017):

Displaying 40 items.

• The HIV glycan shield as a target for broadly neutralizing antibodies (Q26786540) (← links)
• HIV broadly neutralizing antibody targets (Q27026662) (← links)
• Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design (Q28084672) (← links)
• Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope (Q28263655) (← links)
• Assigning and visualizing germline genes in antibody repertoires (Q28640605) (← links)
• Composition and Antigenic Effects of Individual Glycan Sites of a Trimeric HIV-1 Envelope Glycoprotein (Q29306052) (← links)
• Humanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem (Q30234773) (← links)
• Vaccine Elicitation of High Mannose-Dependent Neutralizing Antibodies against the V3-Glycan Broadly Neutralizing Epitope in Nonhuman Primates (Q33612459) (← links)
• HIV-1 Envelope Trimer Design and Immunization Strategies To Induce Broadly Neutralizing Antibodies (Q33753573) (← links)
• Strategies to guide the antibody affinity maturation process (Q35685300) (← links)
• The Broad Neutralizing Antibody Responses after HIV-1 Superinfection Are Not Dominated by Antibodies Directed to Epitopes Common in Single Infection (Q35686970) (← links)
• Broadly Neutralizing Antibody Responses in a Large Longitudinal Sub-Saharan HIV Primary Infection Cohort (Q35894094) (← links)
• Antibodies elicited by yeast glycoproteins recognize HIV-1 virions and potently neutralize virions with high mannose N-glycans (Q36079874) (← links)
• Diversification in the HIV-1 Envelope Hyper-variable Domains V2, V4, and V5 and Higher Probability of Transmitted/Founder Envelope Glycosylation Favor the Development of Heterologous Neutralization Breadth (Q36194234) (← links)
• Mechanisms of escape from the PGT128 family of anti-HIV broadly neutralizing antibodies (Q36531018) (← links)
• Conformational Epitope-Specific Broadly Neutralizing Plasma Antibodies Obtained from an HIV-1 Clade C-Infected Elite Neutralizer Mediate Autologous Virus Escape through Mutations in the V1 Loop (Q36694111) (← links)
• Differential Antibody Responses to Conserved HIV-1 Neutralizing Epitopes in the Context of Multivalent Scaffolds and Native-Like gp140 Trimers (Q37695592) (← links)
• Molecular Architecture of the Cleavage-Dependent Mannose Patch on a Soluble HIV-1 Envelope Glycoprotein Trimer (Q38290294) (← links)
• Germline-targeting immunogens (Q38764547) (← links)
• Genetic and structural analyses of affinity maturation in the humoral response to HIV-1. (Q38992744) (← links)
• Antibody-virus co-evolution in HIV infection: paths for HIV vaccine development (Q39108751) (← links)
• Identification and specificity of broadly neutralizing antibodies against HIV (Q39108796) (← links)
• Chinks in the armor of the HIV-1 Envelope glycan shield: Implications for immune escape from anti-glycan broadly neutralizing antibodies (Q39186163) (← links)
• Structural principles controlling HIV envelope glycosylation (Q39211319) (← links)
• Hidden Lineage Complexity of Glycan-Dependent HIV-1 Broadly Neutralizing Antibodies Uncovered by Digital Panning and Native-Like gp140 Trimer (Q40061438) (← links)
• Cooperation between Strain-Specific and Broadly Neutralizing Responses Limited Viral Escape and Prolonged the Exposure of the Broadly Neutralizing Epitope (Q40134111) (← links)
• Staged induction of HIV-1 glycan-dependent broadly neutralizing antibodies. (Q40290521) (← links)
• Complete epitopes for vaccine design derived from a crystal structure of the broadly neutralizing antibodies PGT128 and 8ANC195 in complex with an HIV-1 Env trimer (Q40957217) (← links)
• Glycan Microheterogeneity at the PGT135 Antibody Recognition Site on HIV-1 gp120 Reveals a Molecular Mechanism for Neutralization Resistance (Q42148324) (← links)
• Brief introduction of current technologies in isolation of broadly neutralizing HIV-1 antibodies. (Q46148243) (← links)
• The Neutralizing Antibody Response To the HIV-1 Env Protein. (Q46180922) (← links)
• Bacterially derived synthetic mimetics of mammalian oligomannose prime antibody responses that neutralize HIV infectivity. (Q46226616) (← links)
• Structural characterization of a highly-potent V3-glycan broadly neutralizing antibody bound to natively-glycosylated HIV-1 envelope. (Q52338929) (← links)
• Coupling of Single Molecule, Long Read Sequencing with IMGT/HighV-QUEST Analysis Expedites Identification of SIV gp140-Specific Antibodies from scFv Phage Display Libraries. (Q52653118) (← links)
• Superinfection Drives HIV Neutralizing Antibody Responses from Several B Cell Lineages that Contribute to a Polyclonal Repertoire. (Q52718554) (← links)
• Defining HIV-1 Envelope N-glycan Microdomains Through Site-specific Heterogeneity Profiles (Q57285042) (← links)
• Development of broadly neutralizing antibodies in HIV-1 infected elite neutralizers (Q58763247) (← links)
• Synthesis of an Undecasaccharide Featuring an Oligomannosidic Heptasaccharide and a Bacterial Kdo-lipid A Backbone for Eliciting Neutralizing Antibodies to Mammalian Oligomannose on the HIV-1 Envelope Spike (Q64099089) (← links)
• Antibody responses to the HIV-1 envelope high mannose patch (Q90677040) (← links)
• Cooperation between somatic mutation and germline-encoded residues enables antibody recognition of HIV-1 envelope glycans (Q92006841) (← links)